SEC Form 4 · accession 0001127602-18-007629
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP,Corporate &Medical Affairs
Period of report
Feb 20, 2018
Accepted (ET)
Feb 21, 2018 · 6:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 20, 2018 | S | 14,435 | $81.5374 | D | 0 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Open Market Sale of Family Trust Shares
- F2Sale prices reported for the transactions reported here range from $81.4601 to $81.60. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.